SHPAX vs. GGHCX
Compare and contrast key facts about Saratoga Health & Biotechnology Fund (SHPAX) and Invesco Health Care Fund (GGHCX).
SHPAX is managed by Saratoga. It was launched on Jul 14, 1999. GGHCX is managed by Invesco. It was launched on Aug 6, 1989.
Performance
SHPAX vs. GGHCX - Performance Comparison
Loading graphics...
SHPAX vs. GGHCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SHPAX Saratoga Health & Biotechnology Fund | -1.13% | 17.43% | 0.26% | -0.36% | 1.93% | 16.71% | 3.52% | 27.67% | -5.30% | 11.78% |
GGHCX Invesco Health Care Fund | -8.65% | 15.48% | 3.96% | 3.05% | -13.53% | 12.05% | 14.52% | 32.01% | 0.27% | 15.51% |
Returns By Period
In the year-to-date period, SHPAX achieves a -1.13% return, which is significantly higher than GGHCX's -8.65% return. Both investments have delivered pretty close results over the past 10 years, with SHPAX having a 6.84% annualized return and GGHCX not far behind at 6.75%.
SHPAX
- 1D
- 0.96%
- 1M
- -6.99%
- YTD
- -1.13%
- 6M
- 10.24%
- 1Y
- 12.17%
- 3Y*
- 6.93%
- 5Y*
- 5.73%
- 10Y*
- 6.84%
GGHCX
- 1D
- 0.65%
- 1M
- -8.58%
- YTD
- -8.65%
- 6M
- -1.69%
- 1Y
- 1.85%
- 3Y*
- 5.07%
- 5Y*
- 2.41%
- 10Y*
- 6.75%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SHPAX vs. GGHCX - Expense Ratio Comparison
SHPAX has a 2.90% expense ratio, which is higher than GGHCX's 1.04% expense ratio.
Return for Risk
SHPAX vs. GGHCX — Risk / Return Rank
SHPAX
GGHCX
SHPAX vs. GGHCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Saratoga Health & Biotechnology Fund (SHPAX) and Invesco Health Care Fund (GGHCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SHPAX | GGHCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.78 | 0.12 | +0.65 |
Sortino ratioReturn per unit of downside risk | 1.18 | 0.28 | +0.90 |
Omega ratioGain probability vs. loss probability | 1.15 | 1.04 | +0.11 |
Calmar ratioReturn relative to maximum drawdown | 1.56 | 0.10 | +1.46 |
Martin ratioReturn relative to average drawdown | 4.30 | 0.32 | +3.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SHPAX | GGHCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.78 | 0.12 | +0.65 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.41 | 0.16 | +0.25 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.41 | 0.39 | +0.03 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.57 | -0.27 |
Correlation
The correlation between SHPAX and GGHCX is 0.83, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
SHPAX vs. GGHCX - Dividend Comparison
SHPAX's dividend yield for the trailing twelve months is around 3.70%, less than GGHCX's 6.22% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SHPAX Saratoga Health & Biotechnology Fund | 3.70% | 3.66% | 1.35% | 5.38% | 6.34% | 3.76% | 13.82% | 13.24% | 22.00% | 17.98% | 12.52% | 10.70% |
GGHCX Invesco Health Care Fund | 6.22% | 5.69% | 5.17% | 0.00% | 0.00% | 24.69% | 6.44% | 3.51% | 8.81% | 6.88% | 2.24% | 15.07% |
Drawdowns
SHPAX vs. GGHCX - Drawdown Comparison
The maximum SHPAX drawdown since its inception was -69.50%, which is greater than GGHCX's maximum drawdown of -40.23%. Use the drawdown chart below to compare losses from any high point for SHPAX and GGHCX.
Loading graphics...
Drawdown Indicators
| SHPAX | GGHCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.50% | -40.23% | -29.27% |
Max Drawdown (1Y)Largest decline over 1 year | -7.87% | -13.53% | +5.66% |
Max Drawdown (5Y)Largest decline over 5 years | -16.32% | -25.37% | +9.05% |
Max Drawdown (10Y)Largest decline over 10 years | -28.05% | -29.34% | +1.29% |
Current DrawdownCurrent decline from peak | -6.99% | -12.96% | +5.97% |
Average DrawdownAverage peak-to-trough decline | -28.07% | -8.82% | -19.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.86% | 4.41% | -1.55% |
Volatility
SHPAX vs. GGHCX - Volatility Comparison
Saratoga Health & Biotechnology Fund (SHPAX) and Invesco Health Care Fund (GGHCX) have volatilities of 4.62% and 4.60%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SHPAX | GGHCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.62% | 4.60% | +0.02% |
Volatility (6M)Calculated over the trailing 6-month period | 9.76% | 9.05% | +0.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.57% | 15.67% | +0.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.19% | 15.50% | -1.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.57% | 17.49% | -0.92% |